Pediatric Gastroenterology, Hepatology & Nutrition

The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition (대한소아소화기영양학회)
권호 표지
DOI QR코드

DOI QR Code

Cholestasis beyond the Neonatal and Infancy Periods

  • Khalaf, Racha (Department of Medical Education, Johns Hopkins All Children's Hospital) ;
  • Phen, Claudia (Department of Medical Education, Johns Hopkins All Children's Hospital) ;
  • Karjoo, Sara (Department of Gastroenterology and Nutrition, Johns Hopkins All Children's Hospital) ;
  • Wilsey, Michael (Department of Gastroenterology and Nutrition, Johns Hopkins All Children's Hospital)
  • Received : 2015.12.13
  • Accepted : 2016.02.16
  • Published : 2016.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

Cholestasis results from impairment in the excretion of bile, which may be due to mechanical obstruction of bile flow or impairment of excretion of bile components into the bile canaliculus. When present, cholestasis warrants prompt diagnosis and treatment. The differential diagnosis of cholestasis beyond the neonatal period is broad and includes congenital and acquired etiologies. It is imperative that the clinician differentiates between intrahepatic and extrahepatic origin of cholestasis. Treatment may be supportive or curative and depends on the etiology. Recent literature shows that optimal nutritional and medical support also plays an integral role in the management of pediatric patients with chronic cholestasis. This review will provide a broad overview of the pathophysiology, diagnostic approach, and management of cholestasis beyond the neonatal and infancy periods.

Keywords

References

  1. Suchy FJ, Sokol RJ, Balistreri WF. Liver disease in children. New York: Cambridge University Press, 2014.
  2. Kremer AE, Bolier R, van Dijk R, Oude Elferink RP, Beuers U. Advances in pathogenesis and management of pruritus in cholestasis. Dig Dis 2014;32:637-45. https://doi.org/10.1159/000360518
  3. Chappell LC, Gurung V, Seed PT, Chambers J, Williamson C, Thornton JG; PITCH Study Consortium. Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial. BMJ 2012;344:e3799. https://doi.org/10.1136/bmj.e3799
  4. Kronsten V, Fitzpatrick E, Baker A. Management of cholestatic pruritus in paediatric patients with alagille syndrome: the King's College Hospital experience. J Pediatr Gastroenterol Nutr 2013;57:149-54. https://doi.org/10.1097/MPG.0b013e318297e384
  5. Moyer V, Freese DK, Whitington PF, Olson AD, Brewer F, Colletti RB, et al; North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Guideline for the evaluation of cholestatic jaundice in infants: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2004;39: 115-28. https://doi.org/10.1097/00005176-200408000-00001
  6. Nathanson MH, Boyer JL. Mechanisms and regulation of bile secretion. Hepatology 1991;14:551-66. https://doi.org/10.1002/hep.1840140324
  7. Keely SJ, Scharl MM, Bertelsen LS, Hagey LR, Barrett KE, Hofmann AF. Bile acid-induced secretion in polarized monolayers of T84 colonic epithelial cells: Structure-activity relationships. Am J Physiol Gastrointest Liver Physiol 2007;292:G290-7. https://doi.org/10.1152/ajpgi.00076.2006
  8. Wagner M, Zollner G, Trauner M. New molecular insights into the mechanisms of cholestasis. J Hepatol 2009;51:565-80. https://doi.org/10.1016/j.jhep.2009.05.012
  9. Trauner M, Meier PJ, Boyer JL. Molecular pathogenesis of cholestasis. N Engl J Med 1998;339:1217-27. https://doi.org/10.1056/NEJM199810223391707
  10. Stringer MD, Taylor DR, Soloway RD. Gallstone composition: are children different? J Pediatr 2003;142: 435-40. https://doi.org/10.1067/mpd.2003.159
  11. Friesen CA, Roberts CC. Cholelithiasis. Clinical characteristics in children. Case analysis and literature review. Clin Pediatr (Phila) 1989;28:294-8. https://doi.org/10.1177/000992288902800701
  12. Katsika D, Grjibovski A, Einarsson C, Lammert F, Lichtenstein P, Marschall HU. Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs. Hepatology 2005; 41:1138-43. https://doi.org/10.1002/hep.20654
  13. O'Neill JA Jr. Choledochal cyst. Curr Probl Surg 1992;29:361-410.
  14. Shah OJ, Shera AH, Zargar SA, Shah P, Robbani I, Dhar S, et al. Choledochal cysts in children and adults with contrasting profiles: 11-year experience at a tertiary care center in Kashmir. World J Surg 2009;33:2403-11. https://doi.org/10.1007/s00268-009-0184-2
  15. Singham J, Yoshida EM, Scudamore CH. Choledochal cysts: part 2 of 3: Diagnosis. Can J Surg 2009;52:506-11.
  16. Panagiotakaki E, Tzetis M, Manolaki N, Loudianos G, Papatheodorou A, Manesis E, et al. Genotype-phenotype correlations for a wide spectrum of mutations in the Wilson disease gene (ATP7B). Am J Med Genet A 2004;131:168-73.
  17. Beasley RP. Rocks along the road to the control of HBV and HCC. Ann Epidemiol 2009;19:231-4.
  18. Schilsky ML, Ala A. Genetic testing for Wilson disease: availability and utility. Curr Gastroenterol Rep 2010; 12:57-61. https://doi.org/10.1007/s11894-009-0084-5
  19. Ranucci G, Socha P, Iorio R. Wilson disease: what is still unclear in pediatric patients? Clin Res Hepatol Gastroenterol 2014;38:268-72. https://doi.org/10.1016/j.clinre.2014.03.002
  20. Srivastava A. Progressive familial intrahepatic cholestasis. J Clin Exp Hepatol 2014;4:25-36. https://doi.org/10.1016/j.jceh.2013.10.005
  21. Jacquemin E. Progressive familial intrahepatic cholestasis. Clin Res Hepatol Gastroenterol 2012;36 Suppl 1:S26-35. https://doi.org/10.1016/S2210-7401(12)70018-9
  22. Jansen PL, Muller MM. Progressive familial intrahepatic cholestasis types 1, 2, and 3. Gut 1998;42:766-7. https://doi.org/10.1136/gut.42.6.766
  23. Alagille D, Habib EC, Thomassin N. L'atresie des voies biliaires intrahepatiques avec voies biliaires extrahepatiques permeables chez l'enfant. Paris: Flammarion, 1969:301-18.
  24. Kamath BM, Bason L, Piccoli DA, Krantz ID, Spinner NB. Consequences of JAG1 mutations. J Med Genet 2003;40:891-5. https://doi.org/10.1136/jmg.40.12.891
  25. Davis AR, Rosenthal P, Escobar GJ, Newman TB. Interpreting conjugated bilirubin levels in newborns. J Pediatr 2011;158:562-5.e1. https://doi.org/10.1016/j.jpeds.2010.09.061
  26. Weiss JS, Gautam A, Lauff JJ, Sundberg MW, Jatlow P, Boyer JL, et al. The clinical importance of a protein-bound fraction of serum bilirubin in patients with hyperbilirubinemia. N Engl J Med 1983;309:147-50. https://doi.org/10.1056/NEJM198307213090305
  27. Harb R, Thomas DW. Conjugated hyperbilirubinemia: screening and treatment in older infants and children. Pediatr Rev 2007;28:83-91. https://doi.org/10.1542/pir.28-3-83
  28. Ovchinsky N, Moreira RK, Lefkowitch JH, Lavine JE. Liver biopsy in modern clinical practice: a pediatric point-of-view. Adv Anat Pathol 2012;19:250-62. https://doi.org/10.1097/PAP.0b013e31825c6a20
  29. Bucuvalas JC, Cutfield W, Horn J, Sperling MA, Heubi JE, Campaigne B, et al. Resistance to the growth-promoting and metabolic effects of growth hormone in children with chronic liver disease. J Pediatr 1990; 117:397-402. https://doi.org/10.1016/S0022-3476(05)81079-0
  30. de Albuquerque Taveira AT, Fernandes MI, Galvao LC, Sawamura R, de Mello Vieira E, de Paula FJ. Impairment of bone mass development in children with chronic cholestatic liver disease. Clin Endocrinol (Oxf) 2007;66:518-23.
  31. Brumbaugh D, Mack C. Conjugated hyperbilirubinemia in children. Pediatr Rev 2012;33:291-302. https://doi.org/10.1542/pir.33-7-291
  32. Keil R, Snajdauf J, Rygl M, Pycha K, Kotalova R, Drabek J, et al. Diagnostic efficacy of ERCP in cholestatic infants and neonates--a retrospective study on a large series. Endoscopy 2010;42:121-6. https://doi.org/10.1055/s-0029-1215372
  33. Bhavsar MS, Vora HB, Giriyappa VH. Choledochal cysts : a review of literature. Saudi J Gastroenterol 2012;18:230-6. https://doi.org/10.4103/1319-3767.98425
  34. Lewis VA, Adam SZ, Nikolaidis P, Wood C, Wu JG, Yaghmai V, et al. Imaging of choledochal cysts. Abdom Imaging 2015;40:1567-80. https://doi.org/10.1007/s00261-015-0381-4
  35. Cai Q, Keilin S, Obideen K, Li Y. Intraduodenal hydrochloric acid infusion for facilitation of cannulation of the dorsal pancreatic duct at ERCP in patients with pancreas divisum: a preliminary study. Am J Gastroenterol 2010;105:1450-1. https://doi.org/10.1038/ajg.2010.88
  36. Ahrar H, Jafarpishe MS, Hekmatnia A, Solouki R, Emami MH. Magnetic resonance cholangiography compared with endoscopic retrograde cholangiography in the diagnosis of primary sclerosing cholangitis. J Res Med Sci 2014;19:1150-4.
  37. Moff SL, Kamel IR, Eustace J, Lawler LP, Kantsevoy S, Kalloo AN, et al. Diagnosis of primary sclerosing cholangitis: a blinded comparative study using magnetic resonance cholangiography and endoscopic retrograde cholangiography. Gastrointest Endosc 2006;64:219-23. https://doi.org/10.1016/j.gie.2005.12.034
  38. Feldstein AE, Perrault J, El-Youssif M, Lindor KD, Freese DK, Angulo P. Primary sclerosing cholangitis in children: a long-term follow-up study. Hepatology 2003;38:210-7.
  39. Eppens EF, van Mil SW, de Vree JM, Mok KS, Juijn JA, Oude Elferink RP, et al. FIC1, the protein affected in two forms of hereditary cholestasis, is localized in the cholangiocyte and the canalicular membrane of the hepatocyte. J Hepatol 2001;35:436-43. https://doi.org/10.1016/S0168-8278(01)00158-1
  40. European Association for Study of Liver. EASL Clinical Practice Guidelines: Wilson's disease. J Hepatol 2012; 56:671-85. https://doi.org/10.1016/j.jhep.2011.11.007
  41. Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Engl J Med 2006;354:731-9. https://doi.org/10.1056/NEJMra052270
  42. Hegade VS, Kendrick SF, Jones DE. Drug treatment of pruritus in liver diseases. Clin Med (Lond) 2015; 15:351-7.
  43. Chang Y, Golkar L. The use of naltrexone in the management of severe generalized pruritus in biliary atresia: report of a case. Pediatr Dermatol 2008;25:403-4. https://doi.org/10.1111/j.1525-1470.2008.00699.x
  44. Stander S, Steinhoff M, Schmelz M, Weisshaar E, Metze D, Luger T. Neurophysiology of pruritus: cutaneous elicitation of itch. Arch Dermatol 2003;139: 1463-70.
  45. Browning J, Combes B, Mayo MJ. Long-term efficacy of sertraline as a treatment for cholestatic pruritus in patients with primary biliary cirrhosis. Am J Gastroenterol 2003;98:2736-41. https://doi.org/10.1111/j.1572-0241.2003.08662.x
  46. Muller C, Pongratz S, Pidlich J, Penner E, Kaider A, Schemper M, et al. Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial. Eur J Gastroenterol Hepatol 1998;10:865-70. https://doi.org/10.1097/00042737-199810000-00010
  47. Nightingale S, Ng VL. Optimizing nutritional management in children with chronic liver disease. Pediatr Clin North Am 2009;56:1161-83. https://doi.org/10.1016/j.pcl.2009.06.005
  48. Mager DR, Wykes LJ, Roberts EA, Ball RO, Pencharz PB. Branched-chain amino acid needs in children with mild-to-moderate chronic cholestatic liver disease. J Nutr 2006;136:133-9. https://doi.org/10.1093/jn/136.1.133
  49. Shneider BL, Magee JC, Bezerra JA, Haber B, Karpen SJ, Raghunathan T, et al; Childhood Liver Disease Research Education Network (ChiLDREN). Efficacy of fat-soluble vitamin supplementation in infants with biliary atresia. Pediatrics 2012;130:e607-14. https://doi.org/10.1542/peds.2011-1423
  50. Shen YM, Wu JF, Hsu HY, Ni YH, Chang MH, Liu YW, et al. Oral absorbable fat-soluble vitamin formulation in pediatric patients with cholestasis. J Pediatr Gastroenterol Nutr 2012;55:587-91. https://doi.org/10.1097/MPG.0b013e31825c9732
  51. Jensen M, Abu-El-Haija M, Bishop W, Rahhal RM. Difficulty achieving vitamin D sufficiency with high-dose oral repletion therapy in infants with cholestasis. J Pediatr Gastroenterol Nutr 2015;61: 187-9. https://doi.org/10.1097/MPG.0000000000000751

Cited by

  1. A Specially Designed Multi-Gene Panel Facilitates Genetic Diagnosis in Children with Intrahepatic Cholestasis: Simultaneous Test of Known Large Insertions/Deletions vol.11, pp.10, 2016, https://doi.org/10.1371/journal.pone.0164058
  2. Bilateral anophthalmia and intrahepatic biliary atresia, two unusual components of Fraser syndrome: a case report vol.20, pp.1, 2016, https://doi.org/10.1186/s12884-020-03048-x